CBD infused cinnamon roll? New York expansion for Cannabis brand Toast Holdings

636853051634027017636742406326852959cannabis marijuana plant.jpg

04 Oct 2018 --- Toast Holdings, Inc., the parent company of luxury Cannabis brand Toast, is launching a new line of CBD oils: Toast CBD Oil Original and Toast CBD Oil Cold Pressed Orange. Toast CBD Oil is an all-natural, full-spectrum hemp extract oil that delivers varying potencies of CBD, which is said to help balance mood, relieve post-exercise pain and calm temporary anxiety. The range of CBD Oils will be launched through New York restaurant by Chloe and will feature in a range of treats.

Cannabis had already been tipped by nutrition and nutraceutical industry experts as an area for growth in North America, with people across different populations showing more curiosity for the ingredient as it gains increasing regulatory acceptance. Innova Market Insights data show that of the global food Click to Enlarge& beverages and supplement product launches featuring CBD in 2018 so far, the US accounts for 76 percent of launches.

“Our Toast Slice, which is a sophisticated, CBD-dominant Cannabis pre-roll, has been a great success in our Western US markets and has resulted in strong demand from consumers nationwide, especially in New York,” says Toast Holdings, Inc., CEO Punit Seth. “Launching Toast CBD Oil aligns with our vision of offering CBD-forward products that provide social and mindful experiences to consumers and we are thrilled to launch it in New York with by CHLOE.”

The Feelz by CHLOE line will include CBD sweets ranging from their popular cinnamon roll and brownie to a pink rice krispie treat, mini cakes, popcorn, granola, whoopie pies, funfetti babka, pet-friendly dog bones, a selection of specialty coffee drinks and bubble teas.

In addition to the Feelz by CHLOE. menu items, both Toast CBD Oil Original and Toast CBD Oil Cold Pressed Orange will be available as an add-on to any coffee menu item and for purchase.

In further cannabis reporting, in a recent interview with NutritionInsight, George Pontiakos, CEO of botanical supplier BI Nutraceuticals explains that he sees the cannabis market as having four areas of demarcation: “older guys who have been using the cannabis flower for ages, young people coming into the market experimenting, medical use of the flower such as for cancer treatments and the edibles, which will be the biggest market.”

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Rooting out the “bad actors”: US FDA promises sweeping regulatory changes for dietary supplements

12 Feb 2019 --- The US Food and Drug Administration (FDA) is seeking to significantly “modernize” dietary supplement regulations, in an attempt to root out “bad actors” that distribute and sell dangerous products. Promised to be the most “significant modernizations” in 25 years, announced steps will seek to ensure that the US regulatory framework is flexible enough to adequately evaluate product safety while also promoting innovation, developing new enforcement strategies and engaging in a dialogue with dietary supplement stakeholders.

Health & Nutrition News

Fermented cannabinoid development green light: Amyris lands US$255m deal

08 Feb 2019 --- Sustainable ingredients company Amyris Inc. has signed a binding term sheet with an unnamed partner in an agreement valued at US$255 million for the development, licensing and commercialization of a new fermented cannabinoid. The deal is expected to be finalized by the end of March after which development of the cannabinoid will immediately begin. The commercialization of the cannabinoid products is reportedly expected within the next 18-24 months, assuming appropriate regulatory approvals.

Health & Nutrition News

The future’s looking green: Hemp innovation thrives at ISM in Cologne

30 Jan 2019 --- Green was a salient color among the candy presented at this year's sweet and snack trade fair, ISM 2019, held in Cologne, Germany. As the cannabis plant and its derivatives, namely hemp and cannabidiol (CBD), have enjoyed an increasingly normalized reputation and popularity among consumers, continuing investment in the well-known plant is highly anticipated for 2019.

Health & Nutrition News

Has the haze lifted? As cannabis-derivatives get the green light, NPD expansion is set to grow

15 Jan 2019 --- Cannabis-derivatives, such as hemp and cannabidiol (CBD), have been increasingly cropping up on ingredients lists in the US and elsewhere. A recent ruling, which came as the US Government launched its farm bill in December 2018, alleviates hemp of its illegal status, which is expected to spur further innovation. Part one of this NutritionInsight two-part report into cannabis-derived products in the nutrition and food industry explored the softening regulatory environment. Part two considers how the industry may respond to the opportunities that such regulation shifts may bring to the US and Canada, for example.

Health & Nutrition News

On an all time high? Cannabis, hemp and CBD green lights fuel NPD surge

08 Jan 2019 --- As a string of regulatory greenlights have begun to move the cannabis plant and cannabis-derived products into an increasingly mainstream track, cannabis-derived products may well be the trend to watch in 2019. The FDA has signaled a softened stance on cannabis-derived products with its most recent move which has legalized hemp and Cannabidiol (CBD) derived from hemp. Such developments are exciting for the innovation front of food and drink products that contain cannabis-derived compounds. The future, it could be said, may be green.

More Articles
URL : http://www.nutritioninsight.com:80/news/cbd-infused-cinnamon-roll-new-york-expansion-for-cannabis-brand-toast-holdings.html